ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Osakkeen ANI Pharmaceuticals, Inc. (ANIP) hinta tänään on eli muutosta on ollut epäluku % siitä, kun markkina avattiin. Yrityksen markkina-arvo on 1,70 mrd. $, ja päivittäisen kaupankäynnin määrä on  osaketta. Edellinen sulkemishinta oli .

Aloitetaanko? Seuraa alla olevia vaiheita tai lue oppaamme siitä, miten ostaa ANI Pharmaceuticals osakkeita Krakenista alkaen 10 dollarista.